Notoxicitysigns(suchashypoactivity,alterationinthelocomotor
activity)ordeathswererecordedduringtheadministrationand
recoveryperiodsbyoralroutewithCDAEindosesof3.0,6.0and
12.0g/kg.Further,nosignificantchangeswererecordedinbody
weightgainofcontrolandtreatedrats